You searched for "training"
Clinical Trials 2 – key papers
Clinical Trials 1 is available here. Case 1 This British study on haematuria clinic diagnostic yield was published in the British Journal of Urology International in 2006. The results are often asked in examinations! Edwards TJ, et al. A prospective...
Solifenacin and mirabegron are safe and effective in combination
Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...
A phase II dose-ranging study of mirabegron in patients with OAB
This was a multinational, multicentre, randomised, double–blind, double-dummy, parallel group placebo- and active- controlled phase II study. The study enrolled 1108 men and women aged 18 and over. The criteria were: patients must have had overactive blader (OAB) symptoms for...Robots
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology which is part of the BAUS website (www.baus.org.uk). In the last four articles I...Malcolm Coptcoat Prize - The Urology Foundation: patient experience in urology
Why attend? Hear from the Medical Director of Health in Justice, on prison medicine and caring for under-represented groups Explore six shortlisted innovation and transformation projects that have improved patient experience in urology Learn how successful initiatives were developed, implemented...RSM: Urothelial cancer: advances, innovation and improving outcomes
Join the Royal Society of Medicine (RSM) Urology Section for this one-day meeting exploring the latest advances in urothelial cancer care. Bringing together leading urologists, oncologists and researchers, the programme will examine developments across the bladder cancer pathway, from diagnosis and transurethral resection of bladder tumour (TURBT) to bladder-sparing treatments, robotic surgery and new systemic therapies.RSM: Key Issues in Endourology
Join the Royal Society of Medicine (RSM) Urology Section for this annual meeting exploring key issues in endourology. Bringing together leading clinicians and innovators, the programme will examine the latest developments in stone disease management, benign prostatic enlargement and the technologies shaping contemporary endourological practice.RSM: Winter Short Papers – Unlocking Better Outcomes Through Quality Improvement
Join the Royal Society of Medicine (RSM) Urology Section for this evening's webinar featuring the Winter Short Papers competition. Participants will hear the six highest-scoring resident doctor presentations on quality improvement and service transformation in urology, followed by a keynote lecture on the latest advances in renal transplantation.Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...
